𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas

✍ Scribed by Rajiv Kumar; Barbro Lundh Rozell; Jari Louhelainen; Kari Hemminki


Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
152 KB
Volume
75
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


CDKN2A (P16INK4a) and CDK4 mutation anal
✍ Elizabeth A. Holland; Helen Schmid; Richard F. Kefford; Graham J. Mann πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 180 KB

Mutation analysis of two genes involved in melanoma susceptibility (CDKN2A/p16 INK4a and CDK4) was undertaken in 131 probands with a family history of melanoma. Screening of all three exons of CDKN2A and exon 2 of CDK4 by single-strand conformation polymorphism (SSCP) analysis and/or direct sequenci

No p16INK4A/CDKN2/MTS1 mutations indepen
✍ Meye, Axel; WΓΌrl, Peter; Hinze, Raoul; Berger, Dieter; Bache, Matthias; Schmidt, πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

The p16 INK4A /CDKN2/MTS1 gene encodes a specific inhibitor of cyclin-dependent kinases (CDKs) 4 and 6. This study investigates p16 INK4A gene status and expression in mesenchymal tumours, in particular soft tissue sarcomas (STSs). Employing non-radioactive polymerase chain reaction-single strand co

Infrequent alterations of the p16INK4A g
✍ Ryuichi Kita; Naoshi Nishida; Yoshihiro Fukuda; Hidemasa Azechi; Yoko Matsuoka; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 French βš– 499 KB πŸ‘ 2 views

We examined the genomic status of the p161NK4A (inhibitor of cyclin-dependent kinase 4 A) and cyclin-dependent kinase 4 (CDK4) genes in 62 human hepatocellular carcinomas (HCCs), 5 cholangiocellular carcinomas and 6 cell lines derived from human liver canceo. Although no samples showed the homozygou